View in EDS

A phase I, pharmacokinetic and pharmacodynamic study of GSK2256098, a focal adhesion kinase inhibitor, in patients with advanced solid tumors.

Saved in:
Bibliographic Details
Title: A phase I, pharmacokinetic and pharmacodynamic study of GSK2256098, a focal adhesion kinase inhibitor, in patients with advanced solid tumors.
Authors: Soria, J. C.1 soria@igr.fr, Gan, H. K.2,3, Blagden, S. P.4, Plummer, R.5, Arkenau, H. T.6, Ranson, M.7, Evans, T. R. J.8, Zalcman, G.9, Bahleda, R.1, Hollebecque, A.1, Lemech, C.6, Dean, E.7, Brown, J.8, Gibson, D.10, Peddareddigari, V.10, Murray, S.10, Nebot, N.10, Mazumdar, J.10, Swartz, L.10, Auger, K. R.10
Source: Annals of Oncology. Dec2016, Vol. 27 Issue 12, p2268-2274. 7p. 5 Charts, 2 Graphs.
Database: Academic Search Ultimate
Be the first to leave a comment!
You must be logged in first